Abstract
An ethanolic extract of Artemisia dracunculus L. (PMI 5011) has been observed to decrease glucose and insulin levels in animal models and enhance cellular signaling in cultured cells. To determine the mechanism of action of PMI-5011, we have measured changes in protein expression in human primary skeletal muscle culture (HSMC) from subjects with Type 2 diabetes. After obtaining skeletal muscle biopsies, HSMCs were initiated, grown to confluence, and exposed to 10 μg/mL PMI 5011 overnight. Two-dimensional difference in-gel electrophoresis was used to separate proteins, and liquid chromatography mass spectrometry was used to identify differentially regulated proteins. Additionally, real-time polymerase chain reaction (PCR) was used to confirm candidate proteins identified. These data demonstrate that a well characterized botanical extract of Artemisia dracunculus L. significantly modulates proteins involved in regulating inflammatory pathways, particularly the NFκB complex system.
Original language | English (US) |
---|---|
Pages (from-to) | 1278-1284 |
Number of pages | 7 |
Journal | Phytotherapy Research |
Volume | 24 |
Issue number | 9 |
DOIs | |
State | Published - Sep 2010 |
All Science Journal Classification (ASJC) codes
- Pharmacology
Keywords
- Botanicals
- Difference in-gel electrophoresis
- Muscle
- Nutrition
- Proteins
- Proteomics